The Jordan Company in its acquisition of PQ Corporation’s performance materials business.
Arya Sciences Acquisition Corp III in its business combination with Nautilus Biotechnology.
Arya Sciences Acquisition Corp II in its business combination with Cerevel Therapeutics.
Trinseo in the €1.137 billion contemplated acquisition of Arkema’s PMMA business.
Arya Sciences Acquisition Corp. in its business combination with Immatics Biotechnologies GmbH.
Huntsman Corporation in its $300 million acquisition of CVC Thermoset Specialties.
Huntsman Corporation in its $350 million acquisition of Icynene-Lapolla.
Bristol-Myers Squibb in its $13.4 billion divesture of Celgene’s OTEZLA® program to Amgen in connection with Bristol-Myers Squibb’s $90 billion acquisition of Celgene.
Huntsman Corporation in its $2.1 billion sale of its chemical intermediates and surfactants businesses to Indorama Ventures.
Fortive Corporation in Industrial Scientific’s $570 million acquisition of Intelex Technologies.
Huntsman Corporation in its $750 million senior notes offering.
